Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual

Induced pluripotent stem cell (iPSC) line (ZZUNEUi009-A) from a healthy female individual

Induced pluripotent stem cells (iPSCs) can be used to generate different types of somatic cells in vitro and are a useful tool for investigating drug and disease mechanisms. Here, we generated human induced pluripotent stem cell (iPSC) line ZZUNEUi009-A from an apparently healthy 28-year-old female...

Full description

Bibliographic Details
Main Authors:	Mengduan Liu, Xiaowei Li, Wanrong Fu, Mengyu Wang, Yangyang Liu, Lu Wang, Liang Hu, Xiaoyan Zhao, Jianzeng Dong
Format:	Article
Language:	English
Published:	Elsevier 2021-05-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506121001215

Similar Items

Generation of a hiPSC line ZZUNEUi012-A from a healthy female individual
by: Mengyu Wang, et al.
Published: (2021-01-01)

Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual
by: Wanrong Fu, et al.
Published: (2021-01-01)

An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human
by: Yangyang Liu, et al.
Published: (2021-03-01)

Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7
by: Xiaowei Li, et al.
Published: (2020-03-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual
by: Jiwei Zhang, et al.
Published: (2020-05-01)

Establishment of a human iPSC (ZZUNEUi026-A) from a dilated cardiomyopathy patient carrying heterozygous Vinculin (c. 625A > T) mutant
by: Yangyang Liu, et al.
Published: (2022-07-01)

An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene
by: Xiaowei Li, et al.
Published: (2020-08-01)

A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy
by: Xiaowei Li, et al.
Published: (2021-03-01)

A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy
by: Xi Zhao, et al.
Published: (2022-04-01)

Generation of a hiPSC line ZZUNEUi017-A from a patient with dilated cardiomyopathy caused by mutation in TTN
by: Shujian Huang, et al.
Published: (2021-04-01)

An integration-free iPSC line ZZUNEUi028-A derived from a patient with hypertrophic cardiomyopathy carrying a heterozygous mutation (c. 1504 C > T) in MYBPC3 gene
by: Dong Cheng, et al.
Published: (2022-08-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi002-A) from a patient with spinocerebellar ataxia type 3
by: Liting Wei, et al.
Published: (2020-08-01)

PLEKHM2 deficiency induces impaired mitochondrial clearance and elevated ROS levels in human iPSC-derived cardiomyocytes
by: Jianchao Zhang, et al.
Published: (2024-03-01)

Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene
by: Lu Wang, et al.
Published: (2021-01-01)

Establishment of TUSMi009-A, an induced pluripotent stem cell (iPSC) line from a 24-year-old Chinese Han patient with gliocytoma
by: Kui Chen, et al.
Published: (2021-10-01)

Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi005-A) from a healthy female Chinese Han
by: Wenzhu Liu, et al.
Published: (2024-06-01)

An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene
by: Kui Zhu, et al.
Published: (2023-09-01)

Establishment of an induced pluripotent stem cell (iPSC) line (INNDSUi001-A) from a healthy female Chinese Han
by: Dongdong Wang, et al.
Published: (2022-07-01)

Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC4
by: Munenari Itoh, et al.
Published: (2016-07-01)

Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC1
by: Munenari Itoh, et al.
Published: (2016-07-01)

Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant
by: Jiangtao Zhao, et al.
Published: (2022-08-01)

Generation of an induced pluripotent stem cell (iPSC) line (BBANTWi009-A) from a Meester-Loeys syndrome patient carrying a BGN mutation
by: Pauline De Kinderen, et al.
Published: (2023-02-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi003-A) from a Wilson's disease patient harboring a homozygous R778L mutation in ATP7B gene
by: Jiwei Zhang, et al.
Published: (2019-12-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi005-A) from a Wilson's disease patient harboring a homozygous Pro992Leu mutation in ATP7B gene
by: Liting Wei, et al.
Published: (2020-08-01)

Suspension culture improves iPSC expansion and pluripotency phenotype
by: Nerea Cuesta-Gomez, et al.
Published: (2023-06-01)

Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A)
by: Abhay Srivastava, et al.
Published: (2022-10-01)

Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency
by: Qi Gu, et al.
Published: (2016-10-01)

Generation of control iPSC lines CBRCULi008-A and CBRCULi009-A derived from lymphoblastoid cell lines
by: Charles-Albert Chapotte-Baldacci, et al.
Published: (2023-09-01)

Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9
by: Jinmeng Bai, et al.
Published: (2023-03-01)

Generation of TSC1 knockout induced pluripotent stem cell (iPSC) line
by: Wei Shan, et al.
Published: (2022-10-01)

Development of human induced pluripotent stem cell (iPSC) line from a 60 year old female patient with multiple schwannoma
by: Shaokun Zhang, et al.
Published: (2017-03-01)

414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer
by: Hui Huang, et al.
Published: (2023-11-01)

A novel method for generating induced pluripotent stem cell (iPSC)-derived alveolar organoids: a comparison of their ability depending on iPSC origin
by: Min Jae Lim, et al.
Published: (2023-07-01)

Deletion of Seipin Attenuates Vascular Function and the Anticontractile Effect of Perivascular Adipose Tissue
by: Mengyu Wang, et al.
Published: (2021-08-01)

Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi010-A) from a healthy Jordanian female skin dermal fibroblasts
by: Nidaa A. Ababneh, et al.
Published: (2020-08-01)

Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi050-A from a healthy donor
by: Xiaomeng Yang, et al.
Published: (2024-02-01)

Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of mutation in SACSIN gene
by: Candela Machuca, et al.
Published: (2018-12-01)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
by: Beevers, J, et al.
Published: (2013)

Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line
by: Wei Shan, et al.
Published: (2021-08-01)

The core mammalian pluripotency network in induced pluripotent stem cell (iPSC) formation : models for genetic and epigenetic reprogramming
by: Abdallah, Hussein(Hussein M.)
Published: (2019)